Acthar Injection
Product Images NDC 63004-8710

Product Visual Gallery

This gallery contains 70 technical images submitted to the FDA as part of the official labeling for Acthar (NDC 63004-8710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Keenova Ard Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation Formula (Acthar 1)

An illustration showing the formula for calculating Body Surface Area (BSA). The formula is BSA (m²) equals the square root of the product of weight in kilograms and height in centimeters divided by 3600.*

FDA Label Image

Image (Acthar 2)

An illustration of a prefilled injection device, featuring a green body and a white top cap, designed for subcutaneous administration of Acthar repository corticotropin. The image depicts the injector pen in an upright position.*

FDA Label Image

Image (Acthar 3)

Illustration of an Acthar injection pen for subcutaneous use, showing labeled components including handle, green colored body, window, gray needle guard, and bottom cap. The diagram highlights the device design for administering repository corticotropin injection.*

FDA Label Image

Image (Acthar 4)

An instructional diagram illustrating parts of a syringe or injector device, highlighting the green colored body, a yellow band indicating the locked gray needle guard, and the gray needle guard itself.*

FDA Label Image

Container Image (Acthar 5)

Acthar Gel 40 USP Units/0.5 mL single-dose pre-filled subcutaneous injection blister pack by Keenova ARD LLC. The label includes usage instructions, a barcode, and storage information specifying refrigeration at 2° to 8°C (36° to 46°F). It is marked for Rx only with NDC 63004-8712-1.*

FDA Label Image

Container Image (Acthar 6)

Label of Acthar Gel repository corticotropin injection, single-dose pre-filled SelfJect injector with a strength of 40 USP Units/0.5 mL for subcutaneous injection only. The label shows instructions for use, storage information, a barcode, and an expiration date field marked as EXP YYYY/MM. The labeler is Keenova ARD LLC.*

FDA Label Image

Image (Acthar 7)

An instructional illustration showing a timer with "45 Min" displayed, alongside a medical device resembling an injection pen and its plastic tray or holder, indicating a 45-minute period related to its use or preparation.*

FDA Label Image

Image (Acthar 8)

An illustration of a subcutaneous injection pen device for Acthar, a repository corticotropin injection. The image highlights the bottom cap of the pen, showing the outer structure and a removable cover at the bottom end used for administering the injection.*

FDA Label Image

Image (Acthar 9)

An illustration showing medical supplies typically used for injection site care, including an alcohol swab, a sharps disposal container, a piece of gauze, an adhesive bandage, and a cotton ball.*

FDA Label Image

Image (Acthar 10)

An instructional illustration showing recommended subcutaneous injection sites on the human body. Highlighted areas include the abdomen, the outer thigh, and the upper arm. The graphic uses simple outlines and shaded blue regions to indicate where injections can be administered.*

FDA Label Image

Image (Acthar 11)

Illustration showing hands being washed under a running faucet with water and soap bubbles, demonstrating proper handwashing technique.*

FDA Label Image

Image (Acthar 12)

Illustration showing a hand applying a small adhesive patch to the skin, demonstrating the application of a topical or transdermal patch. The image suggests how to place the patch securely on the skin surface.*

FDA Label Image

Image (Acthar 13)

An instructional diagram showing a close-up view of a subcutaneous injection device for Acthar repository corticotropin. The image highlights the "Window" feature on the device, illustrating where the user can visually confirm injection status.*

FDA Label Image

Image (Acthar 14)

An instructional illustration showing two hands assembling the needle guard on an injection device. The hand on the left is holding the gray needle guard, while the hand on the right holds the main injection device. An arrow indicates placement of the needle guard onto the device, highlighting the gray needle guard component.*

FDA Label Image

Image (Acthar 15)

An instructional illustration showing a hand holding and positioning a syringe for subcutaneous injection at a 90-degree angle to the skin surface.*

FDA Label Image

Image (Acthar 16)

An instructional illustration showing a hand holding an injection device with a green and white body, pressing it downward toward the skin, indicating subcutaneous administration technique for Acthar repository corticotropin injection.*

FDA Label Image

Image (Acthar 17)

An instructional illustration showing a hand holding an injection device positioned against the skin, with a 'click' sound indicator. This likely demonstrates the method of administering a subcutaneous injection for Acthar repository corticotropin.*

FDA Label Image

Image (Acthar 18)

An instructional illustration showing a hand holding a cylindrical injection device positioned at a 90-degree angle above the skin surface, with an upward arrow indicating the direction for injection or removal. The image visually guides how to hold and position the injection for subcutaneous administration.*

FDA Label Image

Image (Acthar 19)

An illustration showing a device with a white top and a green-colored body that disappears, and a yellow band near the bottom. The graphic labels the green body and yellow band areas, indicating features of the injection device.*

FDA Label Image

Image (Acthar 20)

Illustration showing a specific colored band on a device, highlighting a yellow band around the lower section. The image includes a red circle with a white 'X', indicating an incorrect or cautionary state related to the yellow band placement or visibility on the device.*

FDA Label Image

Image (Acthar 21)

An instructional illustration showing a hand disposing of an injection vial into a red sharps disposal container. This depicts proper disposal procedure for used injection materials.*

FDA Label Image

Image (Acthar 22)

Illustration of a subcutaneous injection device for Acthar repository corticotropin. The labeled parts include a handle at the top, a green-colored body, a window in the middle section, a gray needle guard below the window, and a bottom cap at the base of the device.*

FDA Label Image

Image (Acthar 23)

An instructional illustration showing parts of an injection device for Acthar repository corticotropin. It highlights the green colored body area that disappears, a yellow band indicating a gray needle guard locked position, and the gray needle guard at the base of the device.*

FDA Label Image

Image (Acthar 24)

A circular timer graphic showing 45 minutes, with a partially filled green segment indicating elapsed time. The center displays "45 Min" in bold black text, likely representing a time duration or countdown.*

FDA Label Image

Image (Acthar 25)

An instructional illustration showing a person with three marked areas for subcutaneous injection sites: the abdomen, the front of the thigh, and the upper outer arm. The image highlights preferred locations for administering a subcutaneous injection, commonly used for drugs like Acthar repository corticotropin injection.*

FDA Label Image

Image (Acthar 26)

An illustration showing hands being washed under running water from a faucet, with water droplets depicted around the hands. This image demonstrates proper handwashing technique, likely intended for hygiene or infection control instructions.*

FDA Label Image

Image (Acthar 27)

An instructional illustration showing a hand wiping the skin surface with a small cloth or pad, likely preparing the injection site for Acthar subcutaneous injection.*

FDA Label Image

Image (Acthar 28)

An instructional diagram showing a device with a close-up view of a window feature on its surface, likely part of a medical injection device or vial container. The window is highlighted with a circular magnified overlay and labeled clearly. The image focuses on the device's design detail without additional text or dosage information.*

FDA Label Image

Image (Acthar 29)

An illustration showing hands holding an Acthar injection device and a separate gray needle guard, indicating how the needle guard fits onto the injection device before use. The image is instructional, demonstrating assembly steps for the subcutaneous injection of repository corticotropin.*

FDA Label Image

Image (Acthar 30)

An instructional illustration showing a hand holding a green and white injection device positioned perpendicularly at a 90-degree angle to the skin surface for subcutaneous administration. The image visually demonstrates the proper angle for injecting Acthar repository corticotropin subcutaneously.*

FDA Label Image

Image (Acthar 31)

An instructional illustration depicting a hand holding an injection device vertically above the skin, demonstrating the correct positioning for subcutaneous injection of Acthar repository corticotropin. A downward arrow indicates the injection direction into the skin.*

FDA Label Image

Image (Acthar 32)

Illustration showing a hand holding the Acthar injection device perpendicular to the skin surface, demonstrating a subcutaneous injection technique with an instruction to 'click' the device against the skin.*

FDA Label Image

Image (Acthar 33)

Illustration showing a hand holding an injection device positioned at a 90-degree angle to the skin surface, indicating subcutaneous injection technique with an upward arrow suggesting the direction of needle insertion.*

FDA Label Image

Image (Acthar 34)

An instructional illustration showing a hand disposing of a used Acthar injection vial into a red sharps disposal container. This diagram demonstrates safe disposal of subcutaneous injection materials associated with Acthar (repository corticotropin).*

FDA Label Image

Image (Acthar 35)

Illustration of an injection device likely designed for subcutaneous administration. The device features a white rounded cap and a blue body with a visible button or slider mechanism, suggesting it is an autoinjector or pen-type injector for subcutaneous use.*

FDA Label Image

Image (Acthar 36)

An illustration diagram of an injection device labeled with parts: handle, purple colored body, window, gray needle guard, and bottom cap. The device appears designed for subcutaneous injection, consistent with Acthar repository corticotropin injection packaging.*

FDA Label Image

Image (Acthar 37)

An instructional illustration of a subcutaneous injection device for Acthar repository corticotropin. It highlights the purple-colored body that disappears, a yellow band indicating the gray needle guard is locked, and the gray needle guard itself.*

FDA Label Image

Image (Acthar 38)

Acthar Gel 80 USP U/mL injection label for subcutaneous use only. The package includes a barcode and storage instructions recommending refrigeration at 2 to 8 degrees Celsius. The label displays the product name, strength, dosage form, route of administration, and is labeled for human prescription drug use by Keenova ARD LLC.*

FDA Label Image

Image (Acthar 39)

Label of Acthar Gel repository corticotropin injection, 80 USP Units/mL, contained in a single-dose pre-filled SelfJect injector device. The label specifies it is for subcutaneous injection and includes an expiration date placeholder. The labeler is Keenova ARD LLC.*

FDA Label Image

Image (Acthar 40)

An instructional illustration showing a medical device next to a plastic tray with a clock icon indicating 45 minutes. The device appears to be a dosing or injection tool, depicted with a purple and white color scheme, consistent with subcutaneous injection administration steps.*

FDA Label Image

Image (Acthar 41)

An instructional illustration showing a device labeled with the text 'Bottom Cap' at the bottom. The device appears to be a pen-like injector or similar medical device with a blue body and white cap, indicating the part referred to as the bottom cap for use or removal.*

FDA Label Image

Image (Acthar 42)

An illustration showing components included for injection preparation or aftercare. It displays an alcohol swab packet, a red sharps disposal container, a folded piece of gauze, a small adhesive bandage, and a cotton ball. These items support the use of injectable drugs like repository corticotropin (Acthar).*

FDA Label Image

Image (Acthar 43)

An instructional illustration showing proper subcutaneous injection sites on the human body for Acthar injection. The highlighted areas include the abdomen around the navel, the outer thigh, and the upper arm, indicating where the injection can be administered.*

FDA Label Image

Image (Acthar 44)

Illustration showing hands being washed under a running faucet with water and soap bubbles, demonstrating hand hygiene practices.*

FDA Label Image

Image (Acthar 45)

Illustration showing a hand applying or pressing a small adhesive patch or dressing onto a skin surface, likely demonstrating part of the administration or preparation process for a subcutaneous injection.*

FDA Label Image

Image (Acthar 46)

An instructional diagram depicting the injection device for Acthar repository corticotropin subcutaneous injection. It highlights a close-up view of a specific component labeled as "Window" on the device, showing detail likely related to its function or use during administration.*

FDA Label Image

Image (Acthar 47)

An instructional illustration depicting the removal of a gray needle guard from a prefilled injection syringe held in a hand, indicating preparation for subcutaneous injection. The syringe is partially covered with a label or protective wrapping, and an arrow shows detaching the needle guard.*

FDA Label Image

Image (Acthar 48)

An instructional illustration showing a hand holding an injection device at a 90-degree angle to the skin surface, demonstrating the proper technique for subcutaneous administration of Acthar repository corticotropin injection.*

FDA Label Image

Image (Acthar 49)

Illustration showing a hand holding an injection device, positioned for subcutaneous administration. The device is being pressed downward into the skin, indicated by a downward arrow, representing how to use the Acthar injection for subcutaneous delivery.*

FDA Label Image

Image (Acthar 50)

Instructional illustration showing a hand holding an injection device against the skin, indicating a 'click' sound, suggesting activation or locking of the subcutaneous injection mechanism for Acthar (repository corticotropin) injection.*

FDA Label Image

Image (Acthar 51)

An instructional illustration showing a hand holding an Acthar subcutaneous injection device positioned at a 90-degree angle to the skin, with an arrow indicating an upward motion for proper injection technique.*

FDA Label Image

Image (Acthar 52)

An instructional illustration showing a device with a purple-colored body and a yellow band. A green check mark indicates correct usage, with text noting that the purple-colored body disappears as part of the process shown.*

FDA Label Image

Image (Acthar 53)

An illustration showing a subcutaneous injection device with a yellow band circled and a red X mark indicating incorrect positioning or use of the yellow band on the device.*

FDA Label Image

Image (Acthar 54)

An instructional illustration showing a hand discarding a capped injection device into a sharps disposal container. The image indicates proper disposal of the Acthar injection pen used for subcutaneous administration.*

FDA Label Image

Image (Acthar 55)

An instructional diagram of a subcutaneous injection device for Acthar repository corticotropin. The labeled parts include the handle, purple colored body, window, gray needle guard, and bottom cap, illustrating key components of the injection pen.*

FDA Label Image

Image (Acthar 56)

Illustration showing a subcutaneous injection device with labeled components: a gray needle guard at the bottom, a yellow band indicating the gray needle guard is locked, and a note that a purple colored body disappears as part of the device's operation.*

FDA Label Image

Image (Acthar 57)

A circular timer icon displaying "45 Min" with shaded segments indicating a 45-minute duration, representing a time interval or waiting period.*

FDA Label Image

Image (Acthar 58)

An instructional illustration showing a human figure with three highlighted application sites for a subcutaneous injection: the abdomen, the front thigh, and the upper thigh. Each site is marked with shaded areas to indicate where the injection can be administered.*

FDA Label Image

Image (Acthar 59)

An illustration showing hands being washed under running water from a faucet, emphasizing hand hygiene. Blue bubbles and water droplets depict the flow and cleaning action.*

FDA Label Image

Image (Acthar 60)

Illustration showing a hand holding and swabbing an area of skin, likely to be used before a subcutaneous injection. The image suggests preparation by cleaning the injection site with an antiseptic wipe or swab.*

FDA Label Image

Image (Acthar 61)

Illustration showing a close-up view of an injection pen's window, highlighting the part labeled as "Window". The image likely depicts a detail to help users identify where to check the medication level or dose in the pen device.*

FDA Label Image

Image (Acthar 62)

An instructional illustration showing the removal of a gray needle guard from an injection device held by a person, highlighting preparation for subcutaneous administration of Acthar (repository corticotropin) injection.*

FDA Label Image

Image (Acthar 63)

An instructional diagram illustrating proper injection technique for a subcutaneous injection. It shows a hand holding a syringe at a 90-degree angle to the injection site on the skin, emphasizing correct positioning for administration.*

FDA Label Image

Image (Acthar 64)

An instructional illustration showing a hand administering a subcutaneous injection using a syringe or pen device. The image depicts the device positioned perpendicular to the skin with a downward arrow indicating the injection direction.*

FDA Label Image

Image (Acthar 65)

An instructional illustration showing a hand pressing down on a pen-style injection device against the skin, with a ‘click’ sound effect indicating activation or delivery of the dose. The image likely demonstrates proper use of a subcutaneous injection device.*

FDA Label Image

Image (Acthar 66)

An instructional illustration showing a hand holding a subcutaneous injection device at a 90-degree angle above skin, with an upward arrow indicating the injection direction.*

FDA Label Image

Image (Acthar 67)

Illustration showing the proper disposal method for an injection device. A hand is holding a used injection pen or vial, positioning it above a sharps disposal container for safe disposal.*

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Packaging label for Acthar Gel repository corticotropin injection, 400 USP units/5 mL (80 USP units/mL) in a 5 mL multiple-dose vial. Manufactured for Mallinckrodt ARD LLC. The label includes storage instructions to keep refrigerated between 2 to 8°C and to warm before use. It is indicated for intramuscular or subcutaneous use and contains detailed ingredient information including 80 USP units corticotropin per mL, gelatin, phenol, cysteine, sodium hydroxide, acetic acid, and water for injection.*

FDA Label Image

Principal Display Panel (4 x 0.5 mL Injector Carton)

Packaging label for Acthar Gel 40 USP Units/0.5 mL subcutaneous injection, a single-dose pre-filled SelfJect injector containing repository corticotropin injection. The label shows it is manufactured for Mallinckrodt ARD LLC and includes instructions for use, storage conditions, and product identification with NDC 63004-8712-4.*

FDA Label Image

Principal Display Panel (4 x 1.0 mL Injector Carton)

Packaging label for Acthar Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect Injector, 80 USP Units/mL. The label indicates it is for subcutaneous injection only and includes 4 single-dose pre-filled injectors with instructions for use. Manufactured for Mallinckrodt ARD LLC, Bridgewater, NJ 08807, with barcode and regulatory information visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.